Literature DB >> 6494731

Morphologic features and incidence of spontaneous hyperplastic and neoplastic mammary gland lesions in Wistar rats.

N J Barsoum, A W Gough, J M Sturgess, F A de la Iglesia.   

Abstract

A morphologic study of spontaneous proliferative lesions of the mammary gland was based on histologic examination of mammary glands from 1020 male and 1145 female albino Wistar rats aged 6 to 110 weeks. Three hundred and seventy-five mammary tumors representing an overall incidence of 33% were identified in the female groups, while the males had a total of five tumors which represented an incidence of 0.5%. Histologically, the most common types of tumors in females were: fibroadenoma (236), carcinoma (85), adenoma (40) and fibroma (8). Duct papilloma (1), lobular carcinoma (1), fibrosarcoma (1) and phyllodes tumor (1), were rare and constituted less than 2% of mammary neoplastic lesions. Mammary tumors were rare before one year of age, but increased with age thereafter. Nine percent of female rats studied also had proliferative non-neoplastic lesions that showed a mixture of benign ductular and/or lobular hyperplasia. One hundred and six of these lesions were identified, representing 22% of all grossly palpable nodules, thus stressing the importance of histologic examination of all gross mammary nodules for tumor evaluation.

Entities:  

Mesh:

Year:  1984        PMID: 6494731     DOI: 10.1177/019262338401200104

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  2 in total

1.  Structure-activity relationships in the induction of mammary gland neoplasia in male rats with substituted aminopyrazoles.

Authors:  J E Fitzgerald; E J McGuire; L K Andrews; F A de la Iglesia
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

2.  Spontaneous Mammary Adenocarcinoma in a Twelve-week-old Female Sprague-Dawley Rat.

Authors:  Kazuya Kuzutani; Toshiyuki Shibanushi; Yumi Kangawa; Tohru Kihara
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.